KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Prepaid Assets (2018 - 2025)

Esperion Therapeutics' Prepaid Assets history spans 8 years, with the latest figure at $4.0 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 2.67% year-over-year to $4.0 million; the TTM value through Dec 2025 reached $4.0 million, down 2.67%, while the annual FY2025 figure was $4.0 million, 2.67% down from the prior year.
  • Prepaid Assets reached $4.0 million in Q4 2025 per ESPR's latest filing, up from $2.8 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $34.2 million in Q1 2021 to a low of $504000.0 in Q1 2025.
  • Average Prepaid Assets over 5 years is $8.5 million, with a median of $8.0 million recorded in 2022.
  • Peak YoY movement for Prepaid Assets: surged 1312.92% in 2022, then tumbled 95.54% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $11.2 million in 2021, then fell by 11.7% to $9.9 million in 2022, then tumbled by 54.32% to $4.5 million in 2023, then fell by 7.81% to $4.2 million in 2024, then decreased by 2.67% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for ESPR's Prepaid Assets are $4.0 million (Q4 2025), $2.8 million (Q3 2025), and $5.4 million (Q2 2025).